A detailed history of Ghost Tree Capital, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 1,150,000 shares of NUVB stock, worth $2.69 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares
1,150,000
Holding current value
$2.69 Million
% of portfolio
1.37%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.58 - $3.69 $2.97 Million - $4.24 Million
1,150,000 New
1,150,000 $3.36 Million
Q2 2021

Aug 11, 2021

SELL
$9.22 - $14.48 $4.61 Million - $7.24 Million
-500,000 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$9.0 - $14.57 $4.5 Million - $7.29 Million
500,000 New
500,000 $4.96 Million

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $508M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.